SBFM SUNSHINE BIOPHARMA INC Capital Structure Changes 8-K Filing 2023 - Notification of Non-Compliance with Minimum Bid Price Requirement Sunshine Biopharma received a notification letter from Nasdaq stating that the company no longer meets the minimum bid price requirement for continued listing on The Nasdaq Capital Market, but has been granted an extension until March 18, 2024 to cure the deficiency.Get access to all SEC 8-K filings of the SUNSHINE BIOPHARMA INC